Skip to main content
. 2020 Oct 22;10:18128. doi: 10.1038/s41598-020-75141-2

Figure 3.

Figure 3

Baseline advanced oxidation protein products (AOPPs)/albumin and ischaemia-modified albumin (IMA)/albumin ratios in patients with drug-induced liver injury and healthy controls (HCs). (A) AOPPs/albumin ratio. (B) IMA/albumin ratio. ***P < 0.001. ABSU absorbance units.